Literature DB >> 858083

Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.

P Hechtman.   

Abstract

Separation of the hexosaminidase A (EC 3.2.1.52) and B isozymes of human liver by ion-exchange chromatography results in recovery of greater than 80% of the activity in crude extracts when synthetic substrates are used to monitor enzyme activity. Only 15% of hexosaminidase activity toward the N-acetylgalactosaminyl (N-acetylneuraminyl) galactosyl glucosylceramide (Gm2 ganglioside) substrate is recovered and all of this activity is associated with the hexosaminidase A Fraction. The low level of Gm2 ganglioside hydrolase activity in the hexosaminidase A fraction could be enhanced by coincubation with column fractions which contain hexosaminidase B. The activating factor, which has been partially purified by gel filtration, is a heat-stable protein with a molecular weight of 36 000 and is without enzyme activity toward hexosaminidase substrates. Highly purified hexosaminidase A or crude hexosaminidase A recovered after gel filtration on Sephadex G-100 has no Gm2 ganglioside hydrolase activity. The Gm2 ganglioside hydrolase activity of these hexosaminidase. A preparations can be completely restored by addition of activating factor. The activating factor does not affect the rate of hydrolysis of synthetic substrate or asialo Gm2 ganglioside catalyzed by hexosaminidase A.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 858083     DOI: 10.1139/o77-044

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  11 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Evidence for two cDNA clones encoding human GM2-activator protein.

Authors:  S Nagarajan; H C Chen; S C Li; Y T Li; J M Lockyer
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

3.  The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.

Authors:  M T Bladon
Journal:  Biochem Genet       Date:  1981-10       Impact factor: 1.890

4.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon.

Authors:  T Tamaru; S Fujibayashi; W R Brown; D A Wenger
Journal:  Histochemistry       Date:  1986

6.  The AB-variant of metachromatic leukodystrophy (postulated activator protein deficiency). Light and electron microscopic findings in a sural nerve biopsy.

Authors:  A F Hahn; B A Gordon; J J Gilbert; G G Hinton
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients.

Authors:  J E Goldman; T Yamanaka; I Rapin; M Adachi; K Suzuki; K Suzuki
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

8.  Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.

Authors:  K Inui; D A Wenger
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Purification and properties of the hexosaminidase A-activating protein from human liver.

Authors:  P Hechtman; D LeBlanc
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

10.  Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.

Authors:  P Hechtman; Z Kachra
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.